Balchem Corporation (BCPC)
NASDAQ: BCPC
· Real-Time Price · USD
161.09
1.15 (0.72%)
At close: Aug 19, 2025, 3:59 PM
Balchem Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Product Sales Revenue | 951.95M | 919.95M | 894.32M | 762.09M | 666.19M | 609.74M | 590.79M |
| Product Sales Revenue Growth | +3.48% | +2.87% | +17.35% | +14.39% | +9.26% | +3.21% | n/a |
| Royalty Revenue | 1.74M | 2.49M | 3.19M | 4.5M | 4.29M | 4.36M | 4.49M |
| Royalty Revenue Growth | -30.18% | -22.06% | -29.15% | +4.99% | -1.58% | -2.83% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 230.38M | 232.84M | 260.12M | 214.36M | 187.3M | 168.67M | 160.99M |
| Non-Us Revenue Growth | -1.05% | -10.49% | +21.35% | +14.45% | +11.04% | +4.77% | n/a |
| United States Revenue | 723.3M | 689.6M | 682.24M | 584.66M | 516.35M | 475.03M | 482.69M |
| United States Revenue Growth | +4.89% | +1.08% | +16.69% | +13.23% | +8.70% | -1.59% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 32.49M | 32M | 34.38M | 32.52M | 33.21M | 35.74M | 32.72M | 29.06M | 30.72M | 35.31M | 32.29M | 31.81M | 29.03M | 29.94M | 25.52M | 25.27M | 25.95M | 25.4M | 25.52M | 24.65M | 25.89M | 26.35M | 27.77M | 25.28M | 24.66M | 19.72M | 20.82M | 20M | 22.62M | 21.48M | 22.47M | 20.41M | 19.65M | 19.91M | 20.56M | 20.03M | 21.2M | 20.91M | 16.16M | 18.74M | 16.6M | 16.64M |
| Selling, General, and Administrative Revenue Growth | +1.53% | -6.92% | +5.73% | -2.08% | -7.07% | +9.22% | +12.59% | -5.39% | -13.01% | +9.35% | +1.52% | +9.56% | -3.02% | +17.29% | +1.03% | -2.66% | +2.17% | -0.47% | +3.55% | -4.81% | -1.74% | -5.12% | +9.87% | +2.49% | +25.07% | -5.27% | +4.10% | -11.58% | +5.30% | -4.43% | +10.09% | +3.89% | -1.31% | -3.15% | +2.65% | -5.51% | +1.35% | +29.39% | -13.76% | +12.90% | -0.26% | n/a |
| Research and Development Revenue | 4.66M | 4.66M | 4.51M | 4.33M | 3.85M | 4.1M | 3.94M | 3.87M | 3.79M | 3.45M | 3.04M | 3M | 2.92M | 3.23M | 4.72M | 3.16M | 2.9M | 2.75M | 2.37M | 2.69M | 2.57M | 2.7M | 2.93M | 2.7M | 2.85M | 2.9M | 3.25M | 2.54M | 3.23M | 2.57M | 2.5M | 2.71M | 2.28M | 1.81M | 1.78M | 1.68M | 1.92M | 1.94M | 1.54M | 1.51M | 1.49M | 1.45M |
| Research and Development Revenue Growth | 0.00% | +3.37% | +4.18% | +12.32% | -6.00% | +4.17% | +1.76% | +1.92% | +10.00% | +13.41% | +1.54% | +2.53% | -9.56% | -31.55% | +49.56% | +8.87% | +5.46% | +15.94% | -11.92% | +4.79% | -4.85% | -7.88% | +8.60% | -5.36% | -1.49% | -11.01% | +28.07% | -21.36% | +25.73% | +2.84% | -7.89% | +18.95% | +25.62% | +1.85% | +6.01% | -12.45% | -1.13% | +26.10% | +1.99% | +1.21% | +3.04% | n/a |